Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation.
Kissel, T., Ge, C., Hafkenscheid, L., Kwekkeboom, J.C., Slot, L.M., Cavallari, M., He, Y., van Schie, K.A., Vergroesen, R.D., Kampstra, A.S.B., Reijm, S., Stoeken-Rijsbergen, G., Koeleman, C., Voortman, L.M., Heitman, L.H., Xu, B., Pruijn, G.J.M., Wuhrer, M., Rispens, T., Huizinga, T.W.J., Scherer, H.U., Reth, M., Holmdahl, R., Toes, R.E.M.(2022) Sci Adv 8: eabm1759-eabm1759
- PubMed: 35138894 
- DOI: 10.1126/sciadv.abm1759
- Primary Citation of Related Structures:  
6YXK, 6YXL, 6YXM - PubMed Abstract: 
The hallmark autoantibodies in rheumatoid arthritis are characterized by variable domain glycans (VDGs). Their abundant occurrence results from the selective introduction of N-linked glycosylation sites during somatic hypermutation, and their presence is predictive for disease development ...